DIA China 2024 Annual Meeting

The upcoming DIA China 2024 Meeting will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.

Join us at Booth #CE05 and dive into the future of drug development & innovation with Ergomed’s pioneering pharmaceutical safety services and global CRO expertise, particularly in oncology and rare diseases.

 

Meet our Experts at #DIAChina24!


Junbao Qiu
PrimeVigilance Director of Operations


Lina Svedlund
Ergomed Director of Business Development & Alliance Management


Daorong Zhang
Ergomed Business Development

 

We look forward to seeing you.